Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 193

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 193
---
 share price volatility, free risk interest rate, dividends
and the expected option term. Expected volatility was calculated based on the average of the standard deviation of a sample of similar
companies. The expected option term represents the period that the Company’s share options are expected to be outstanding and is
determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions.

| q. | Goodwill: |

Goodwill is
recorded as a result of business combination. Goodwill represents the excess of the purchase price in a business combination over the
fair value of identifiable net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment
test.

ASC No. 350,
“Intangibles - Goodwill and other” (“ASC No. 350”) requires goodwill to be tested for impairment at the reporting
unit level at least annually or between annual tests in certain circumstances, and written down when impaired.

<div align='center'>F-15</div>

REVIUM RX.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Cont.)

ASC No. 350
allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment
test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing
is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed.
Alternatively, ASC No. 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing
the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an
impairment of goodwill for the amount of this excess.

The Company
will perform the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment
indicators are present and compares the fair value of the reporting unit with its carrying value.

During the period commencing July
23, 2024 through December 31, 2024, no goodwill impairment losses have been identified.

| r. | Accounting pronouncement recently adopted |

In November
2023, the FASB issued ASU 2023-07, “Improvements to Reportable Segment Disclosures (Topic 280)” which requires enhanced disclosure
of (1) significant segment expenses that are